As of 2025-07-14, the Relative Valuation of Insmed Inc (INSM) is (82.06) USD. This relative valuation is based on P/E multiples. With the latest stock price at 98.18 USD, the upside of Insmed Inc based on Relative Valuation is -183.6%.
The range of the Relative Valuation is (77.55) - (99.02) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 13.9x - 22.7x | 15.3x |
| Forward P/E multiples | 12.1x - 17.8x | 14.2x |
| Fair Price | (77.55) - (99.02) | (82.06) |
| Upside | -179.0% - -200.9% | -183.6% |
| Date | P/E |
| 2025-07-10 | -17.38 |
| 2025-07-09 | -17.34 |
| 2025-07-08 | -17.28 |
| 2025-07-07 | -17.43 |
| 2025-07-03 | -17.58 |
| 2025-07-02 | -17.66 |
| 2025-07-01 | -17.55 |
| 2025-06-30 | -18.09 |
| 2025-06-27 | -17.88 |
| 2025-06-26 | -18.29 |
| 2025-06-25 | -18.85 |
| 2025-06-24 | -19.04 |
| 2025-06-23 | -18.95 |
| 2025-06-20 | -18.46 |
| 2025-06-18 | -17.88 |
| 2025-06-17 | -18.03 |
| 2025-06-16 | -18.26 |
| 2025-06-13 | -17.75 |
| 2025-06-12 | -17.41 |
| 2025-06-11 | -17.61 |
| 2025-06-10 | -16.35 |
| 2025-06-09 | -12.71 |
| 2025-06-06 | -13.23 |
| 2025-06-05 | -13.08 |
| 2025-06-04 | -13.25 |
| 2025-06-03 | -13.14 |
| 2025-06-02 | -12.88 |
| 2025-05-30 | -12.53 |
| 2025-05-29 | -12.44 |
| 2025-05-28 | -11.93 |
| 2025-05-27 | -12.23 |
| 2025-05-23 | -12.14 |
| 2025-05-22 | -11.89 |
| 2025-05-21 | -11.87 |
| 2025-05-20 | -12.32 |
| 2025-05-19 | -12.20 |
| 2025-05-16 | -12.24 |
| 2025-05-15 | -12.08 |
| 2025-05-14 | -11.79 |
| 2025-05-13 | -11.81 |
| 2025-05-12 | -12.18 |
| 2025-05-09 | -11.70 |
| 2025-05-08 | -11.80 |
| 2025-05-07 | -12.27 |
| 2025-05-06 | -12.20 |
| 2025-05-05 | -13.05 |
| 2025-05-02 | -13.00 |
| 2025-05-01 | -13.06 |
| 2025-04-30 | -12.94 |
| 2025-04-29 | -12.83 |